MDSchynsAnesthesia: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MDSchynsAnesthesia
Largest movements
- Cash +€64,093
up €64,093 (+113.0%), from €56,699 to €120,792
mainly Net result for the year (+€53,512) and Tax, wage and social debts (+€13,815)
- Deferred charges and accrued income -€1,905
down €1,905 (-24.9%), from €7,665 to €5,759
- Tangible fixed assets +€1,660
up €1,660, from €0 to €1,660
- Reserves +€53,512
up €53,512 (+133.9%), from €39,956 to €93,467
- Tax, wage and social debts +€13,815
up €13,815 (+90.3%), from €15,305 to €29,120
- Other debts -€2,792
down €2,792 (-50.1%), from €5,570 to €2,778
- Gross operating margin +€9,390
up €9,390 (+16.1%), from €58,309 to €67,698
- Depreciation -€2,732
down €2,732 (-95.8%), from €2,852 to €120
- Taxes -€1,489
down €1,489 (-9.7%), from €15,305 to €13,815
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €64,364 | €128,711 | +€64,347 | +100.0% |
| Formation expenses | 20 | €0 | - | = | |
| Fixed assets | 21/28 | €0 | €1,660 | +€1,660 | |
| Tangible fixed assets | 22/27 | €0 | €1,660 | +€1,660 | |
| Furniture and vehicles | 24 | €0 | €1,660 | +€1,660 | |
| Current assets | 29/58 | €64,364 | €127,051 | +€62,687 | +97.4% |
| Amounts receivable within one year | 40/41 | - | €500 | +€500 | |
| Trade receivables | 40 | - | €500 | +€500 | |
| Cash at bank and in hand | 54/58 | €56,699 | €120,792 | +€64,093 | +113.0% |
| Deferred charges and accrued income | 490/1 | €7,665 | €5,759 | -€1,905 | -24.9% |
| Total equity and liabilities | 10/49 | €64,364 | €128,711 | +€64,347 | +100.0% |
| Equity | 10/15 | €42,956 | €96,467 | +€53,512 | +124.6% |
| Contributions | 10/11 | €3,000 | €3,000 | = | 0.0% |
| Reserves | 13 | €39,956 | €93,467 | +€53,512 | +133.9% |
| Distributable reserves | 133 | €39,956 | €93,467 | +€53,512 | +133.9% |
| Amounts payable | 17/49 | €21,408 | €32,243 | +€10,835 | +50.6% |
| Amounts payable within one year | 42/48 | €21,408 | €32,243 | +€10,835 | +50.6% |
| Trade debts | 44 | €533 | €345 | -€188 | -35.3% |
| Suppliers | 440/4 | €533 | €345 | -€188 | -35.3% |
| Taxes, remuneration and social security | 45 | €15,305 | €29,120 | +€13,815 | +90.3% |
| Taxes | 450/3 | €15,305 | €29,120 | +€13,815 | +90.3% |
| Other amounts payable | 47/48 | €5,570 | €2,778 | -€2,792 | -50.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,852 | €120 | -€2,732 | -95.8% |
| Other operating charges | 640/8 | €176 | €101 | -€75 | -42.5% |
| Gross operating margin | 9900 | €58,309 | €67,698 | +€9,390 | +16.1% |
| Operating profit (loss) | 9901 | €55,281 | €67,477 | +€12,197 | +22.1% |
| Financial charges | 65/66B | €20 | €150 | +€130 | +651.0% |
| Recurring financial charges | 65 | €20 | €150 | +€130 | +651.0% |
| Profit (loss) for the period before taxes | 9903 | €55,261 | €67,327 | +€12,066 | +21.8% |
| Income taxes | 67/77 | €15,305 | €13,815 | -€1,489 | -9.7% |
| Profit (loss) for the period | 9904 | €39,956 | €53,512 | +€13,556 | +33.9% |
| Profit (loss) for the period to be appropriated | 9905 | €39,956 | €53,512 | +€13,556 | +33.9% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.